Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fluoroquinolones in paediatrics.

H S Jafri1, G H McCracken

  • 1Department of Pediatrics, University of Texas Southwestern Medical Center at Dallas, USA. hjafri@mednet.swmed.edu

Drugs
|December 20, 1999
PubMed
Summary

Fluoroquinolones offer broad-spectrum antimicrobial activity, but their pediatric use is limited by arthropathy concerns. Further investigation into their efficacy for specific pediatric infections is warranted.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase 1 study of MEDI3902, an investigational anti-Pseudomonas aeruginosa PcrV and Psl bispecific human monoclonal antibody, in healthy adults.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2018
Same author

Antibody-based therapy to combat Staphylococcus aureus infections.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2017
Same author

The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance.

The Journal of antimicrobial chemotherapy·2015
Same author

Anterior poliomyelitis; from a patient's point of view.

Physiotherapy·2010
Same author

Tigecycline therapy significantly reduces the concentrations of inflammatory pulmonary cytokines and chemokines in a murine model of Mycoplasma pneumoniae pneumonia.

Antimicrobial agents and chemotherapy·2009
Same author

Respiratory tract infection with Mycoplasma pneumoniae in interleukin-12 knockout mice results in improved bacterial clearance and reduced pulmonary inflammation.

Infection and immunity·2006

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Pediatrics

Background:

  • Fluoroquinolones exhibit broad-spectrum antimicrobial activity against various pathogens, including gram-positive, gram-negative, mycobacterial, and atypical organisms.
  • These antibiotics possess favorable pharmacokinetic properties such as excellent oral bioavailability, good tissue penetration, and long elimination half-lives.
  • Pediatric use of fluoroquinolones has been restricted due to safety concerns regarding arthropathy, primarily derived from animal studies, although definitive cases in humans are not well-documented.

Purpose of the Study:

  • To evaluate the potential clinical efficacy and tolerability of fluoroquinolones in treating specific pediatric infections.
  • To address the limited clinical experience with fluoroquinolones in pediatric populations.

Main Methods:

  • Review of existing literature on fluoroquinolone use in pediatric patients.
  • Identification of specific pediatric infections where fluoroquinolones could offer therapeutic advantages.

Main Results:

  • While animal studies raised concerns about arthropathy, no definitive cases of fluoroquinolone-associated arthropathy have been clearly described in pediatric literature.
  • Fluoroquinolones demonstrate broad-spectrum activity relevant to several challenging pediatric infections.

Conclusions:

  • The clinical efficacy and tolerability of fluoroquinolones warrant further investigation in pediatric patients with specific conditions.
  • Potential areas for further study include cystic fibrosis with Pseudomonas infections, gram-negative infections (UTIs, osteomyelitis), febrile neutropenia, multidrug-resistant Streptococcus pneumoniae meningitis, enteric pathogens, and mycobacterial infections.

Related Experiment Videos